ALSEN — Sensorion SA Share News
0.000.00%
Last trade - 00:00Brief: Sensorion Appoints Scott D. Myers As Chairman Of Board
Brief: Sensorion Surpasses Enrollment Target For SENS-401 In SSNHL
Brief: Sensorion End-June Cash Position At Around EUR 55 Mln
Brief: Sensorion Says Regulators Approve Amendment To Phase 2 AUDIBLE-S Trial Of SENS-401
Brief: Sensorion And Sonova To Partner On Age-Related Hearing Loss Study
Brief: Sensorion, Cochlear To Begin First Clinical Trial Of SENS-401
Brief: Sensorion FY Net Loss Narrows To EUR 9 Million
Brief: Sensorion Presents New Preclinical Data On SENS-401 At ARO 2021
Brief: Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur
Brief: Sensorion Is Financed With Cash Runway That Extends Until H2 2022
Europe Research Roundup: Bunzl, Next, Porsche SE
Brief: Sensorion Updates On Progress In Development Of SENS-401 For Prevention Of Hearing Loss
Brief: Sonova Invests 5 Million Euros In Sensorion
Brief: Sensorion and Novasep Sign Gene Therapy Product Development and Manufacturing Agreement
Brief: Sensorion H1 Operating Loss Narrows To 4.7 Million Euros
Brief: Sensorion Obtains 3 Million Euros Loans
Brief: Sensorion Raises About EUR 31 Million In Oversubscribed Private Placement
Brief: Sensorion Appoints Edwin Moses As Chairman Of The Board
Brief: Sensorion Announces Initiation Of Coverage By Chardan